GSK wins latest Zantac trial as jury finds drug did not cause woman’s cancer pharma GSK - formerly GlaxoSmithKline - has won its latest trial over whether its most popular drug caused cancer on Monday, after a jury found it was not the root cause of an American woman's illness.
GSK: Pharma giant raises guidance after second quarter sales give shot in the arm Business London-listed pharma giant GSK has raised its guidance after a strong second quarter beat market expectations, boosted by its cancer and HIV portfolio. Total sales in the second quarter of 2024 reached £7.9bn, an increase of 13 per cent year on year. Core operating profit at the pharma company rose by 18 per cent on [...]
GSK moves into New Oxford Street office in boost for central London Pharma GSK has opened the doors to its new West End office - called the Earnshaw.
US drug giant Pfizer beats GSK to UK government contract for 4.9m vaccine shots June 25, 2024 Pfizer has beaten GSK to win a contract to supply millions of doses of a new respiratory vaccine in the UK after the government snubbed the local drugmaker.
Election 2024: Firms have ‘nothing to worry about’ on workers’ rights, Reeves says June 21, 2024 Rachel Reeves has told businesses they have “nothing to worry about” from Labour’s workers' rights reforms at The Times CEO Summit.
GSK: Good news for pharma giant as approval granted to expand vaccine use June 10, 2024 The FDA has expanded its approval of a GSK vaccine that prevents respiratory syncytial virus (RSV) to affect younger adults, in a move the company hopes will prevent thousands of hospitalisations each year.
GSK shares drag the FTSE 100 as company faces muli-billion pound bill after Zantac trial ruling June 3, 2024 GSK has hit back against a US ruling that found it could be sued over the potential cancer-causing properties of its heartburn drug Zantac.
GSK: How much could the Zantac lawsuits cost? June 3, 2024 Last month, Shore Capital analysts estimated that up to $30bn (£24bn) for litigation was already priced into GSK’s shares.
GSK raises 2024 guidance after strong vaccine sales May 1, 2024 In its first quarter, British company GSK said sales rose 10 per cent to £7.4bn but total operating profit fell 18 per cent to £1.49bn.
Covid-19 anniversary: How have GSK and Astrazeneca fared since? March 23, 2024 The Covid-19 pandemic also ignited interest in the pharmaceutical sector. Even before the UK went into lockdown, the sector was looking for ways to fight the virus.